Dopamine agonists (DAs) like cabergoline and bromocriptine are the first-line treatment for prolactin-secreting tumors, with cabergoline being over 90% effective in normalizing prolactin levels and decreasing tumor size.2 Here, PRL is linked to neoplasm.